Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Markowitz, L. E. Drolet, M. Lewis, R. M. Lemieux-Mellouki, P. Pérez, N. Jit, M. Brotherton, J. M. Ogilvie, G. Kreimer, A. R. Brisson, M.

Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Goodman, E. Reuschenbach, M. Kaminski, A. Ronnebaum, S.

Human Papillomavirus Vaccine Impact and Effectiveness in Six High-Risk Populations: A Systematic Literature Review

  • All age groups
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Whitehouse, E. R. Mandra, A. Bonwitt, J. Beasley, E. A. Taliano, J. Rao, A. K.

Human rabies despite post-exposure prophylaxis: a systematic review of fatal breakthrough infections after zoonotic exposures

  • All age groups
  • Rabies
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Schietzel, S. Anderegg, M. Limacher, A. Born, A. Horn, M. P. Maurer, B. Hirzel, C. Sidler, D. Moor, M. B.

Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Meshram, H. S. Kute, V. Rane, H. Dave, R. Banerjee, S. Mishra, V. Chauhan, S.

Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2022 ∙ Bailey, A. J. M. Maganti, H. B. Cheng, W. Shorr, R. Arianne Buchan, C. Allan, D. S.

Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Yoo, J. J. Yon, D. K. Lee, S. W. Shin, J. I. Kim, B. K.

Humoral Immunogenicity to SARS-CoV-2 Vaccination in Liver Transplant Recipients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Martins-Branco, D. Nader-Marta, G. Tecic Vuger, A. Debien, V. Ameye, L. Brandão, M. Punie, K. Loizidou, A. Willard-Gallo, K. Spilleboudt, C. Awada, A. Piccart, M. de Azambuja, E.

Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Müller, K. E. Dohos, D. Sipos, Z. Kiss, S. Dembrovszky, F. Kovács, N. Solymár, M. Erőss, B. Hegyi, P. Sarlós, P.

Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Shoar, S. Prada-Ruiz, A. C. C. Patarroyo-Aponte, G. Chaudhary, A. Sadegh Asadi, M.

Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...